DRI busts illegal drug manufacturing facility in Jewar, UP; 30 kg drugs seized and two persons arrested
Issued by Ministry of Finance
Read or download the official PDF of this gazette notification issued by the Ministry of Finance on 13th August 2026. Classified under Press Release.
Executive Summary & Key Takeaways
Executive Summary On August 9–10, 2026, the Directorate of Revenue Intelligence (DRI) dismantled a clandestine drug manufacturing facility operating within a residential premises in Jewar, Uttar Pradesh. The operation resulted in the seizure of 30 kg of Amphetamine and 30 kg of precursor chemicals, alongside the arrest of a foreign national and an Indian associate. This action is part of a broader, intensified campaign by the DRI to disrupt illicit drug production and trafficking networks across India.
Key Points / Main Content
Jewar Operation and Seizures
- Contraband Seized: Approximately 30 kg of Amphetamine in intermediary forms and 30 kg of precursor chemicals were recovered.
- Equipment Confiscated: The DRI seized a fully equipped manufacturing setup, including electrical furnaces, hose pipes, scientific measuring equipment, and various reagents.
- Legal Action: Two individuals—a foreign national and an Indian female associate—were arrested under the provisions of the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985.
Modus Operandi of the Accused
- Location Strategy: The facility was operated out of a residential area to avoid detection by local residents.
- Logistics: Manufacturing equipment and raw materials were brought to the premises under the cover of night.
- Operational Cycle: The facility would operate for approximately one week, after which the equipment was removed and the premises cleaned; this cycle was repeated every two to three months.
Recent Enforcement Successes
- Gujarat: A Mephedrone manufacturing facility was recently busted in Ankleshwar, resulting in three arrests.
- Satara, Maharashtra: An Alprazolam and Diazepam facility was dismantled, with the seizure of 400 litres of raw materials and two arrests.
- Ambernath, Maharashtra: A Tramadol manufacturing and export network was intercepted, preventing the export of 100,000 tablets to Nigeria and resulting in three arrests.
Impact Analysis
Directorate of Revenue Intelligence (DRI) Impact The agency has successfully dismantled multiple clandestine laboratories and intercepted sophisticated trafficking networks. Action Required The DRI must maintain its intensified focus on identifying and dismantling the entire ecosystem of illicit manufacture, including procurement, financing, and trafficking.
The Accused (Foreign National and Indian Associate) Impact Both individuals have been apprehended and are facing criminal charges for violating the NDPS Act, 1985. Action Required The accused are subject to further preliminary investigations and legal proceedings as per the provisions of the Act.
Illicit Drug Manufacturing Networks Impact These networks face significant disruption of their production infrastructure and the exposure of their methods for evading detection. Action Required N/A (The document describes these entities as targets of enforcement rather than assigning them specific compliance actions).
Local Residents Impact The dismantling of the Jewar facility removes a clandestine and potentially hazardous industrial operation from a residential neighborhood. Action Required The document notes that the accused operated in short cycles specifically to avoid the suspicion of this group.